AAV8 mutant capsids employ specific point mutations to evade neutralizing antibodies while maintaining high transduction efficiency.
A bicistronic AAV vector delivers two siRNA cassettes to silence SOD1 in astrocytes and neurons.
Replacing triplet codons with quadruplets prevents unauthorized biological resource use without complex genome modifications.
Combining AUF1 vectors with microdystrophin stabilizes the sarcolemma to address inadequate treatments for dystrophinopathies.
A modified adenoviral vector incorporates serotype 45 hexon and fiber proteins to enhance gene delivery efficiency.
A 3300-4200 nucleotide stuffer sequence fills the adeno-associated virus genome, resolving heterogeneity from regulatory elements and improving virion purity.
Self-splicing introns enable efficient circular RNA production with reduced immunogenicity, avoiding expensive enzymatic catalysts.
A short PrSSL promoter sequence drives high protein expression levels in poxvirus vectors.
Stably integrated Rep and E2A genes eliminate transient transfection cytotoxicity, reducing DNA reagent costs while increasing viral titers.
A tag cassette enables specific detection and isolation of stem cells, resolving heterogeneity challenges in regenerative medicine.
Immediate early promoters drive antigen expression before vector antigens, reversing immunodominance hierarchies to boost CD8 T cell responses.
An inducible expression cassette uses an amino acid response element to drive precise gene transcription in host cells.
Engineered E. coli strains produce soluble recombinant proteins without N-terminal methionine residues.
Introducing non-native amino acids into adeno-associated virus capsid proteins increases transduction efficiency while reducing immunogenicity.
Expression cassettes integrate CTCF binding insulators with a truncated beta-globin locus control region to drive erythroid-specific gene transfer.